当前位置: 首页 > 期刊社介绍 > 中国药房 >

《中国药房》杂志是国家卫生健康委员会主管、中国医院协会和重庆大学附属肿瘤医院联合主办的国家级、国内外公开发行的药学综合类学术刊物。读者对象主要为在医院药学部(药剂科)工作的各级各类专业技术人员,以及药品研制、生产、经营、临床应用及监督管理人员。自1990年1月创刊以来,《中国药房》杂志始终秉承“创中国刊业名牌,为医药卫生导航”的办刊宗旨,在全国各级各类医院、医药高等院校、医药研究院(所)等都拥有稳定的作者和读者队伍,行业影响广泛。

《中国药房》杂志目前为半月刊。主要栏目包括:医药热点(包括专家论坛、当前医药前沿、重点理论选题、指南/共识及解读等)、药事管理(包括医药卫生政策、医院药房管理、市场分析及招投标、社会药房、执业药师等)、药学研究(包括基础研究、制剂与工艺、药物分析与检定、中药与民族药等)、药物经济学(包括经济学研究、医保相关研究等)、药物与临床(包括用药观察、精准治疗、血药浓度监测、临床药理、不良反应等)、循证药学(包括临床用药系统评价、循证研究等)、药师与药学服务(包括用药数据分析、处方点评、用药监护、社区药学等)、综述等。为提升刊物印刷质量,从2021年3月第32卷第5期开始,《中国药房》杂志在保持原有特色风格的基础上,将内文改为全彩印刷。全彩印刷能向读者提供更全面、准确的信息,亦能完整体现科学工作者的研究成果。

在中国知网公布的《2021中国学术期刊影响因子年报(自然科学与工程技术版)》中显示,《中国药房》再次名列药学类期刊首位(Q1区首位)。影响力指数(CI)、复合总被引、期刊综合总被引在全国“药学”70种学术期刊中均排名第一。

《中国药房》杂志目前系“中文核心期刊”“中国科技核心期刊”“中国科技论文统计源期刊”“中国期刊方阵双效期刊”“RCCSE中国核心学术期刊”“《中国学术期刊影响因子年报》统计源期刊”“《国家科技期刊开放平台》收录期刊”,于2009~2014期间多次被列入“中国科学引文数据库来源期刊(CSCD)”;被“中文生物医学期刊文献数据库(CMCC)”“中国生物医学期刊引文数据库(CMCI)”“中国期刊全文数据库(CJFD)”“中国生物医学文献检索分析系统光盘数据库(CBMdisc)”“《世界期刊影响力指数(WJCI)报告》(2020科技版)”“美国《化学文摘》(CA)”“俄罗斯《文摘杂志》(AJ)”“美国《国际药学文摘》(IPA)”“WHO西太平洋地区医学索引(WPRIM)”“美国《乌利希期刊指南》(UPD)”“日本科学技术振兴机构数据库(JST)”等国内外重要数据库收录;先后数次获得原卫生部和重庆市优秀期刊评比一等奖、第一届国家卫生计生委优秀期刊奖、第一届重庆市政府出版奖、第三届国家期刊奖、“2018年中国最美医药卫生期刊”、“纪念新中国成立70周年重庆市品牌期刊”“2020年重庆市最美期刊”等众多荣誉,并入选2019年北京国际图书博览会(BIBF)“庆祝中华人民共和国成立70周年精品期刊展”;连年在重庆市期刊综合质量考核中被评为一级期刊,在重庆市期刊编校质量考核中被评为优秀期刊,并连续9年获得重庆市出版专项资金资助(自2013年起)。

Journal ofChina Pharmacy-A Brief Introduction

Journal ofChina Pharmacy, supervised by the National Health Commission of the People’s Republic of China and operated by China Hospital Association and Chongqing University Cancer Hospital, is a comprehensive state-level journal of pharmacy published both at home and abroad. The journal aims at those readers engaged in hospital pharmacy (Dept. of Pharmacy) as well as those engaged in the research & development, production, operation and clinical use of medicines and pharmaceutical administrators. The journal was founded in Jan. 1990 and has always adhered to the purpose of "creating a famous brand of China's publishing industry, guiding the medical and healthy business". It has a stable team of authors and readers in hospitals at all levels, medical colleges and universities and medical research institutes across the country, and has a wide influence in the industry.

At present, the items of journal ofChina Pharmacy, semimonthly journal, contain Medical and Pharmaceutical Hotspots (involving Experts Forum, Current Medical Frontier, Key Theoretical Topics, Guidelines/Consensus and Interpretation), Pharmaceutical Administration (involvingMedical and Health Policy, Hospital Pharmacy Administration, Market Analysis and Bidding, Community Drugstore, Licensed Pharmacist), Pharmacy Research (involving Fundamental Research, Preparation and Technology, Drug Analysis and Determination, Traditional Chinese Medicine and Ethnic Medicine), Pharmacoeconomics (involving Economics Research, Research on Medical Insurance), Drugs and Clinic (involving Medication Observation, Precise Treatment, Monitoring of Blood Concentration, Clinical Pharmacology, Adverse Drug Reaction), Evidence-based Pharmacy (involving System Evaluation of Clinical Drug Use, Evidence-based Research), Pharmacist and Pharmaceutical Care (involving Analysis of Drug Data, Prescription Comment, Administration Monitoring, Community Pharmacy), Review, etc. To improve the printing quality of the journal, from Vol. 32, No. 5 in March 2021, the text of the journal is printed with full color instead on the basis of maintaining the original characteristic style, which can not only provide readers with more comprehensive and accurate information but also fully reflect the research results of scientists.

According to2021 Annual Report for Chinese Academic Journal Impact Factors (Natural Science)published by CNKI, journal ofChina Pharmacyranked first among pharmaceutical journals again (in Q1 area).

Journal ofChina Pharmacyis indexed in “Core Journal of China”, “Source Journal for Chinese Scientific and Technical Papers and Citations”, “Scien-tech Periodical for Statistics Source in China”, “Chinese Periodical Matrix Double-Effect Periodical”, “RCCSE Chinese Core Academic Journal”, “Source Journal forAnnual Report for Chinese Academic Journal Impact Factors” and “Source Journal forChina Open Access Journals(COAJ)”. Journal ofChina Pharmacyhad been praised as “Source Journal for Chinese Science Citation Database (CSCD)” during 2009-2014, and is included by Chinese Medical Current Content (CMCC), CMCI, Chinese Journal Full Text Database (CFJD), Chinese Biomedical Database on disc (CBMdisc), World Journal Clout Index (WJCI) Report (2020 STM), Chemical Abstracts (CA) of US, Abstract Journal (AJ) of Russia, International Pharmaceutical Abstract (IPA), Western Pacific Region Index Medicus (WPRIM) of WHO, Ulrich’s Periodicals Directory (UPD), Database of Japan Science and Technology Agency (JST), etc. Journal ofChina Pharmacysucceeded in winning many prizes such as the First Excellent-Journal Prize of Ministry of Public Health and Chongqing, the First-Assembly Excellent-Journal Prize of the National Health and Family Planning Commission and the First-Assembly Publication Award of Chongqing Government, and was the winner of the Third-Assembly China National Periodical Prize, 2018 China's Most Beautiful Medical and Health Journal Prize, Chongqing Brand Periodicals of Seventieth Anniversary of the Founding of the People's Republic of China, 2020 Chongqing Most Beautiful Journal Award. Journal ofChina Pharmacywas selected in the "Excellent Periodical Exhibition of Seventieth Anniversary of the Founding of the People's Republic of China" of 2019 Beijing International Book Fair (BIBF). The journal has been praised as a first-class periodical in the comprehensive quality assessment of Chongqing periodicals for consecutive years, as well as an excellent periodical in the quality assessment of editing and proofreading of Chongqing periodicals, and has been supported by the special fund for publishing of Chongqing for 9 consecutive years since 2013.

主管单位:国家卫生健康委员会

主办单位:中国医院协会 重庆大学附属肿瘤医院

编 辑:中国药房编辑出版中心

出 版:《中国药房》编辑部

地 址:重庆市渝中区大坪正街129号四环大厦8层

邮 编:400042

电 话:023-63830521、63830907(编辑部)

023-68586727、68586827(新媒体与期刊事务部)

邮 箱:info@china-pharmacy.com

网 址:http://www.china-pharmacy.com

http://www.pharmacyvision.net

邮发代号:78-33

国际标准连续出版物号:ISSN 1001-0408

国内统一连续出版物号:CN 50-1055/R

Responsible Institution

National Health Commission, P.R. China

Sponsored by

Chinese Hospital Association

Chongqing University Cancer Hospital

Edited by

China Pharmacy Editorial and Publishing Center

Published by

China Pharmacy Editorial Department

Postal Address

8th Floor, Sihuan Building, 129 Daping Main Street, Yuzhong District, Chongqing 400042, China

Phone

+86-23-63830521;+86-23-63830907; +86-23-68586727;+86-23-68586827

Email

info@china-pharmacy.com

Website

http://www.china-pharmacy.com

http://www.pharmacyvision.net

Post-distribution Serial Number78-33

CSSN ISSN 1001-0408

CN 50-1055/R